Revealing targeted therapeutic opportunities in triple-negative breast cancers: a new strategy.
Publication
, Journal Article
Poage, GM; Hartman, ZC; Brown, PH
Published in: Cell Cycle
September 1, 2013
Duke Scholars
Published In
Cell Cycle
DOI
EISSN
1551-4005
Publication Date
September 1, 2013
Volume
12
Issue
17
Start / End Page
2705 / 2706
Location
United States
Related Subject Headings
- Triple Negative Breast Neoplasms
- Interleukin-8
- Interleukin-6
- Humans
- Female
- Developmental Biology
- Animals
- 3101 Biochemistry and cell biology
- 0601 Biochemistry and Cell Biology
Citation
APA
Chicago
ICMJE
MLA
NLM
Poage, G. M., Hartman, Z. C., & Brown, P. H. (2013). Revealing targeted therapeutic opportunities in triple-negative breast cancers: a new strategy. Cell Cycle, 12(17), 2705–2706. https://doi.org/10.4161/cc.25871
Poage, Graham M., Zachary C. Hartman, and Powel H. Brown. “Revealing targeted therapeutic opportunities in triple-negative breast cancers: a new strategy.” Cell Cycle 12, no. 17 (September 1, 2013): 2705–6. https://doi.org/10.4161/cc.25871.
Poage GM, Hartman ZC, Brown PH. Revealing targeted therapeutic opportunities in triple-negative breast cancers: a new strategy. Cell Cycle. 2013 Sep 1;12(17):2705–6.
Poage, Graham M., et al. “Revealing targeted therapeutic opportunities in triple-negative breast cancers: a new strategy.” Cell Cycle, vol. 12, no. 17, Sept. 2013, pp. 2705–06. Pubmed, doi:10.4161/cc.25871.
Poage GM, Hartman ZC, Brown PH. Revealing targeted therapeutic opportunities in triple-negative breast cancers: a new strategy. Cell Cycle. 2013 Sep 1;12(17):2705–2706.
Published In
Cell Cycle
DOI
EISSN
1551-4005
Publication Date
September 1, 2013
Volume
12
Issue
17
Start / End Page
2705 / 2706
Location
United States
Related Subject Headings
- Triple Negative Breast Neoplasms
- Interleukin-8
- Interleukin-6
- Humans
- Female
- Developmental Biology
- Animals
- 3101 Biochemistry and cell biology
- 0601 Biochemistry and Cell Biology